Potentiation of the cytotoxicity of peplomycin against Ehrlich ascites carcinoma by bleomycin hydrolase inhibitors

J Antibiot (Tokyo). 1987 Dec;40(12):1794-5. doi: 10.7164/antibiotics.40.1794.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bleomycin / administration & dosage*
  • Carcinoma, Ehrlich Tumor / drug therapy*
  • Cell Survival / drug effects
  • Cysteine Endopeptidases*
  • Drug Synergism
  • Female
  • Glycoside Hydrolases / antagonists & inhibitors*
  • Leucine / administration & dosage
  • Leucine / analogs & derivatives*
  • Leupeptins / administration & dosage*
  • Mice
  • Oligopeptides / administration & dosage*
  • Peplomycin

Substances

  • Leupeptins
  • Oligopeptides
  • Bleomycin
  • Peplomycin
  • Glycoside Hydrolases
  • Cysteine Endopeptidases
  • bleomycin hydrolase
  • Leucine
  • leupeptin
  • E 64